R&D Strategy Overview - The company is focusing on both organic and inorganic growth in its R&D strategy, particularly in the science of the immune system and the application of technologies [1][2] - Over the past three years, the company has aimed to create a research unit focused R&D organization [2] Internal and External Components - The business development (BD) team, led by Chris Sheldon, reports directly to the Chief Scientific Officer, indicating a strategic design to integrate both external and internal opportunities in portfolio decision-making [3] - The focus has been on transitioning into marketed assets, which has driven the company's recent activities [3]